Lucy Dan
@lucydan.bsky.social
Convergence Science PhD student at the Institute of Cancer Research and Imperial College London.
Reposted by Lucy Dan
Congratulations to @alexisbarr.bsky.social and Jesus Gil who have received funding awards, together totalling around £3M, from @cancerresearchuk.org!
They will lead two exciting projects that could result in discoveries that make a real difference to the lives of people with cancer in the future.
They will lead two exciting projects that could result in discoveries that make a real difference to the lives of people with cancer in the future.
LMS scientists receive funding to boost cancer research
Cancer Research UK has awarded significant funding to researchers at the MRC Laboratory of Medical Sciences (LMS) to lead two exciting new projects that could result in discoveries that make a real di...
lms.mrc.ac.uk
September 3, 2025 at 3:05 PM
Congratulations to @alexisbarr.bsky.social and Jesus Gil who have received funding awards, together totalling around £3M, from @cancerresearchuk.org!
They will lead two exciting projects that could result in discoveries that make a real difference to the lives of people with cancer in the future.
They will lead two exciting projects that could result in discoveries that make a real difference to the lives of people with cancer in the future.
Reposted by Lucy Dan
New research from Steve Cutty and @alexisbarr.bsky.social published in the British Journal of Cancer shows the protein p21 promotes survival in lung cancer cells strengthening the rationale for targeting p21 as a cancer treatment. This work was also funded by @cancerresearchuk.org
Blocking the cell cycle inhibitor p21 prevents regrowth in lung cancer cells
Blocking the activity of a protein called p21 stops lung cancer cells entering a ‘sleep-like’ state that allows them to survive chemotherapy. Blocking p21 causes more cancer cells to die and reduces t...
lms.mrc.ac.uk
January 3, 2025 at 11:33 AM
New research from Steve Cutty and @alexisbarr.bsky.social published in the British Journal of Cancer shows the protein p21 promotes survival in lung cancer cells strengthening the rationale for targeting p21 as a cancer treatment. This work was also funded by @cancerresearchuk.org